528116 | PI 3-Kα Inhibitor VIII - CAS 372196-77-5 - Calbiochem

528116
Le prix n'a pas pu être récupéré
Minimum Quantity needs to be mulitiple of
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
Demander le prix
Disponibilité limitée Disponibilité limitée
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Remaining : Will advise
      Nous vous tiendrons informé
      Voir les Prix & la Disponibilité
         ComparerClick To Print This Page

      Overview

      Replacement Information

      Tableau de caractéristiques principal

      Empirical Formula CAS #
      C₁₆H₁₄N₅O₄SBr • HCl • 2H₂O 372196-77-5

      Prix & Disponibilité

      RéférenceDisponibilité Conditionnement Qté Prix Quantité
      528116-5MG
      Récupération des données relatives à la disponibilité...
      Disponibilité limitée Disponibilité limitée
      Interrompu(e)
      Disponible en quantités limitées
      Disponibilité à confirmer
        Remaining : Will advise
          Nous vous tiendrons informé

          5 mg
          Prix en cours de récupération
          Le prix n'a pas pu être récupéré
          Minimum Quantity needs to be mulitiple of
          À la validation de la commande Plus d'informations
          Vous avez sauvegardé ()
           
          Demander le prix
          Description
          Overview A cell-permeable imidazopyridine compound that acts as a highly potent and ATP-competitive DNA-PK and p110α-selective PI3-K inhibitor (IC50 = 0.3, 40, 100, and 850 nM for p110α, p110γ, PI 3-K C2β, and p110β, respectively). Shown to effectively block cellular PI3-K/Akt signaling and inhibit tumor growth both in vitro (IC50 ≤58 nM in MCF7, MCF7 ADR-res, HeLa, A375, and A549 cultures) and in mice in vivo (62% inhibition of HeLa xenograft in 2 weeks, 50 mg/kg/day, i.p.).
          Catalogue Number 528116
          Brand Family Calbiochem®
          Synonyms N-((1E)-(6-Bromoimidazo[1,2-a]pyridin-3-yl)methylene)-Nʹ-methyl-Nʹʹ-(2-methyl-5-nitrobenzene)sulfonohydrazide, HCl, PI 3-K Inhibitor VIII, PIK-75
          References
          References Kim, S., et al. 2007. Blood 110, 4206.
          Hayakawa, M., et al. 2007. Bioorg. Med. Chem. 15, 5837.
          Knight, Z.A., et al. 2007. Cell 125, 733.
          Product Information
          CAS number 372196-77-5
          Form Pale yellow solid
          Hill Formula C₁₆H₁₄N₅O₄SBr • HCl • 2H₂O
          Chemical formula C₁₆H₁₄N₅O₄SBr • HCl • 2H₂O
          Molar Mass 524.8
          Hygroscopic Hygroscopic
          Structure formula Image
          Applications
          Biological Information
          Purity ≥95% by HPLC
          Physicochemical Information
          Solubility DMSO
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Regulatory Review
          Storage +2°C to +8°C
          Protect from Light Protect from light
          Hygroscopic Hygroscopic
          Do not freeze No
          Special Instructions Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          FDS

          Langues
          Argentina Australia Belgie
          Belgien Belgique Brasil
          Canadian English Canadian French Ceská Rep
          Chile China Colombia
          Cyprus Danmark Deutschland
          Eesti Ellas English
          España France Hrvatska 
          Iceland India Indonesia
          Italia Korea Latvija
          Lietuva Magyarország Malta
          México Nederland  Norge
          Peru Polska Portugal
          Schweiz Slovenija Slovensko
          Srpski Standard EU English Suisse
          Suomi Sverige Taiwan
          Thailand Türkiye US English
          United Kingdom Éire Österreich
          България Россия

          Certificats d'analyse

          TitreNuméro de lot
          528116

          Références bibliographiques

          Aperçu de la référence bibliographique
          Kim, S., et al. 2007. Blood 110, 4206.
          Hayakawa, M., et al. 2007. Bioorg. Med. Chem. 15, 5837.
          Knight, Z.A., et al. 2007. Cell 125, 733.
          Fiche technique

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision 13-December-2013 JSW
          Synonyms N-((1E)-(6-Bromoimidazo[1,2-a]pyridin-3-yl)methylene)-Nʹ-methyl-Nʹʹ-(2-methyl-5-nitrobenzene)sulfonohydrazide, HCl, PI 3-K Inhibitor VIII, PIK-75
          Description A cell-permeable imidazopyridine compound that acts as a highly potent and ATP-competitive DNA-PK and p110α-selective PI3-K inhibitor (IC50 = 0.3, 40, 100, and 850 nM for p110α, p110γ, PI 3-K C2β, and p110β, respectively). Shown to effectively block cellular PI3-K/Akt signaling and inhibit tumor growth both in vitro (IC50 ≤58 nM in MCF7, MCF7 ADR-res, HeLa, A375, and A549 cultures) and in mice in vivo (62% inhibition of HeLa xenograft in 2 weeks, 50 mg/kg/day, i.p.).
          Form Pale yellow solid
          Intert gas (Yes/No) Packaged under inert gas
          CAS number 372196-77-5
          Molar mass 524.8
          Chemical formula C₁₆H₁₄N₅O₄SBr • HCl • 2H₂O
          Structure formula
          Purity ≥95% by HPLC
          Solubility DMSO (10 mg/ml)
          Storage +2°C to +8°C
          Protect from light
          Hygroscopic
          Do Not Freeze No
          Special Instructions Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Toxicity Regulatory Review
          References Kim, S., et al. 2007. Blood 110, 4206.
          Hayakawa, M., et al. 2007. Bioorg. Med. Chem. 15, 5837.
          Knight, Z.A., et al. 2007. Cell 125, 733.